Brain
|
|
|
|
|
|
Nervous system
|
HSA04080 Neuroactive ligand receptor interaction
|
223
|
2.34
|
< 0.0005
|
0.0000
|
|
HSA04720 Long-term potentiation
|
62
|
−2.15
|
< 0.0005
|
0.0023
|
|
HSA04540 Gap junction
|
77
|
−1.75
|
< 0.0005
|
0.0429
|
|
HSA04360 Axon guidance
|
125
|
−1.81
|
< 0.0005
|
0.0480
|
Immune system
|
HSA04060 Cytokine-cytokine receptor interaction
|
212
|
2.72
|
< 0.0005
|
< 0.0005
|
|
HSA04610 Complement and coagulation cascades
|
47
|
2.32
|
< 0.0005
|
< 0.0005
|
|
HSA04650 Natural killer cell mediated cytotoxicity
|
95
|
1.70
|
0.0015
|
0.0379
|
|
HSA04612 Antigen processing and representation
|
42
|
1.67
|
0.0049
|
0.0397
|
|
HSA04640 Hematopoietic cell lineage
|
66
|
2.09
|
< 0.0005
|
0.0004
|
Signaling pathways
|
HSA01430 Cell communication
|
118
|
2.14
|
< 0.0005
|
0.0004
|
|
HSA04630 Jak-STAT signaling pathway
|
137
|
2.07
|
< 0.0005
|
0.0005
|
|
HSA04070 Phosphatidylinositol signaling system
|
65
|
1.77
|
0.0029
|
0.0420
|
|
HSA04910 Insulin signaling pathway
|
126
|
1.80
|
< 0.0005
|
0.0455
|
Metabolism
|
HSA00150 Androgen and estrogen metabolism
|
33
|
1.84
|
0.0043
|
0.0118
|
|
HSA00590 Arachidonic acid metabolism
|
39
|
1.81
|
0.0017
|
0.0147
|
|
HSA00361 γ-hexachlorocyclohexane degradation
|
17
|
1.69
|
0.0118
|
0.0370
|
|
HSA00020 Citrate cycle
|
25
|
1.93
|
0.0023
|
0.0375
|
|
HSA00592 α-linolenic acid metabolism
|
15
|
1.70
|
0.0127
|
0.0392
|
|
HSA00251 Glutamate metabolism
|
30
|
1.87
|
0.0038
|
0.0430
|
Folding, sorting, and degradation
|
HSA04120 Ubiquitin mediated proteolysis
|
36
|
1.78
|
0.0039
|
0.0453
|
|
HSA04130 Snare interactions in vesicular transport
|
29
|
1.84
|
< 0.0005
|
0.0450
|
Blood
|
|
|
|
|
|
Signaling pathways |
HSA04070 Phosphatidylinositol signaling system |
65 |
1.78 |
< 0.0005 |
0.0500 |